Long-Term Survival of Patients with Stage T1N0M1 Renal Cell Carcinoma
Viktoria Schütz, Huan Lin, Adam Kaczorowski, Stefanie Zschäbitz, Dirk Jäger, Albrecht Stenzinger, Anette Duensing, Jürgen Debus, Markus Hohenfellner, Stefan Duensing · 2023
Read Long-Term Survival of Patients with Stage T1N0M1 Renal Cell Carcinoma by Viktoria Schütz, Huan Lin, Adam Kaczorowski, Stefanie Zschäbitz, Dirk Jäger, Albrecht Stenzinger, Anette Duensing, Jürgen Debus, Markus Hohenfellner, Stefan Duensing (2023) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-10741977.txt.
Description
Viktoria Schütz and nine co-authors present a 2023 study on a rare kidney cancer group: patients whose small, local tumor has already spread. Tumors under seven centimeters usually carry a fine outlook, yet some patients show distant spread at diagnosis. Little was known about their survival or tumor biology. The team followed twenty-seven such patients and compared them with eighteen patients whose tumors had not spread.
Median cancer survival was far shorter in the spread group, about three years against about eighteen. Yet nearly a third of the spread group lived past five years, and three lived past ten. Some benefited from intense combined treatment aimed at both the kidney tumor and its spread sites. Their tumors also held more immune cells, hinting at fiercer biology. The authors conclude long survival is possible with strong multimodal care.
Catalog record
| CREATOR | Viktoria Schütz, Huan Lin, Adam Kaczorowski, Stefanie Zschäbitz, Dirk Jäger, Albrecht Stenzinger, Anette Duensing, Jürgen Debus, Markus Hohenfellner, Stefan Duensing |
|---|---|
| YEAR | 2023 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 17 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |